Activation of PPARgamma by rosiglitazone attenuates intestinal Cl- secretion. [electronic resource]
Producer: 20090804Description: G82-9 p. digitalISSN:- 1522-1547
- Administration, Oral
- Animals
- Calcium -- metabolism
- Carbachol -- pharmacology
- Chlorides -- metabolism
- Cholera Toxin
- Colforsin -- pharmacology
- Colon -- drug effects
- Cyclic AMP -- metabolism
- Cystic Fibrosis Transmembrane Conductance Regulator -- metabolism
- Diarrhea -- chemically induced
- Disease Models, Animal
- Electric Impedance
- Female
- Gastrointestinal Agents -- administration & dosage
- HT29 Cells
- Humans
- Ileum -- drug effects
- Intermediate-Conductance Calcium-Activated Potassium Channels -- metabolism
- Intestinal Mucosa -- metabolism
- Intestinal Secretions -- drug effects
- Intestines -- drug effects
- Jejunum -- drug effects
- KCNQ1 Potassium Channel -- metabolism
- Mice
- PPAR gamma -- agonists
- Pioglitazone
- Rosiglitazone
- Sodium-Potassium-Chloride Symporters -- metabolism
- Solute Carrier Family 12, Member 2
- Thiazolidinediones -- administration & dosage
- Time Factors
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.